Monte Rosa Therapeutics, Inc
Monte Rosa Therapeutics is seeking a Senior Research Associate I/II to support the design and execution of in vivo proof-of-concept studies across oncology, inflammatory disease, and autoimmune disease programs. This role involves working closely with cross-functional teams to execute in vivo pharmacology studies that characterize the activity and mechanism of action of novel compounds. The position requires working in an AAALAC-accredited Animal Care Facility and providing occasional evening and weekend study support.
Monte Rosa Therapeutics is a biotechnology company pioneering molecular glue degrader (MGD) therapies that promote specific protein ubiquitination and subsequent proteasomal degradation of disease-causing, traditionally undruggable proteins. Their drug discovery platform integrates expertise in MGD chemistry, artificial intelligence, structural biology, and proteomics to rapidly advance programs targeting undruggable or inadequately drugged targets with unprecedented specificity. Focused on cancer and beyond, the company operates out of Boston, MA and Basel, Switzerland.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc didn’t post a salary, so this is our estimate from similar listings.
44% below the average for this role
Senior Research Associate, Preclinical Pharmacology
Nurix
Sr Senior Scientist – Autoimmunity, Immunology and Inflammation
Regeneron Pharmaceuticals
Scientist I/II, In Vivo Pharmacology
Nurix
Inflammation Research - In Vivo Pharmacology Senior Scientist
Amgen
Associate Scientist
Medicilon Inc
Scientist I
WuXi AppTec